| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |